News
New Non-BioLINCC Resource: INHALD Study (specimens and data)
Posted on August 28, 2020
The Investigating HIV-Associated Lung Disease (INHALD) study has been posted to website as a non-BioLINCC resource for biospecimens and study datasets.
For more information:
https://biolincc.nhlbi.nih.gov/studies/inhald-non/
https://biolincc.nhlbi.nih.gov/nonbiolincc_resources/
New Study: CARE-MARS (data)
Posted on August 24, 2020
A new study, Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for GUIDE-IT
Posted on August 13, 2020
Data have been updated for the Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) study. The data now include quality of life data.
New Study: CARE-AIMS (data)
Posted on August 12, 2020
A new study, Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS), has been posted to BioLINCC. Data from this study are available for requests.
New Study: ATTRACT (data)
Posted on July 28, 2020
A new study, Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (ATTRACT), has been posted to BioLINCC. Data from this study are available for requests.
New Study: PETAL-LOTUS FRUIT (data)
Posted on July 1, 2020
A new study, Prevention and Early Treatment of Acute Lung Injury (PETAL) - Low Tidal Volume Universal Support Feasibility of Recruitment for Interventional Trial (LOTUS FRUIT), has been posted to BioLINCC. Data from this study are available for requests.
New Study: CARE-BADGER (data)
Posted on May 26, 2020
A new study, Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER), has been posted to BioLINCC. Data from this study are available for requests.
New Funding Opportunity: BioData Catalyst Research Opportunity
Posted on May 22, 2020
A second round of the NHLBI BioData Catalyst Fellows Program fellowship opportunities has just been announced. Please encourage early-career researchers in your community to apply.
The application process opens on May 15, 2020. The deadline to submit is June 26, 2020 11:59 PM Eastern Time. For more information, please review the Call for Proposals on the BioData Catalyst website.
Questions regarding the Fellows Program may be directed to the NHLBI BioData Catalyst Help Desk and by selecting the type “Fellows Program” from the contact form.
For details on additional funding opportunities go to: Funding Opportunities
New Study: iCOMPARE (data)
Posted on May 20, 2020
A new study, Individualized Comparative Effectiveness of Models Optimizing Patient Safety and Resident Education (iCOMPARE), has been posted to BioLINCC. Data from this study are available for requests.
New Study: REDS III-U.S. Zika (data)
Posted on May 4, 2020
A new study, Recipient Epidemiology and Donor Evaluation Study III (REDS III) U.S. Natural History Cohort of Zika Virus RNA Positive Blood Donors (U.S. Zika), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for FHS-Cohort
Posted on May 1, 2020
Data have been updated for the Framingham Heart Study-Cohort (FHS-Cohort). The data now include examination data from the first 32 clinical exams, selected ancillary data, and event follow-up through 2017.
Data Update for FHS-Offspring
Posted on April 27, 2020
Data have been updated for the Framingham Heart Study (FHS) Offspring (OS) and OMNI 1 Cohorts. The data now include Framingham Offspring examination data from the first 9 clinical exams and selected ancillary data and event follow-up through 2017. Also included are the first 4 exams from the OMNI 1 cohort.
Data Update for MESA
Posted on April 22, 2020
Data have been updated for the Multi-Ethnic Study of Atherosclerosis (MESA). The data now include examination MESA clinical events through calendar year 2015 and MESA ejection fraction from CHF events through calendar year 2015.
New Study: AsthmaNet-Microbiome (data)
Posted on April 15, 2020
A new study, AsthmaNet Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment, has been posted to BioLINCC. Data from this study are available for requests.
Data Update for ARIC Study
Posted on April 14, 2020
Data have been updated for the Atherosclerosis Risk in Communities Study (ARIC) study including cohort follow-up data through 2016. Now available are data from v1-v5 examination cycles, collated annual follow-up communication data for contact years 2-28, and follow-up for mortality, heart disease, and stroke events through 2016 in addition to 7 ancillary studies.
New Study: AsthmaNet-ALFA (data)
Posted on April 2, 2020
A new study, AsthmaNet Proof of Concept Study of Alendronate for Asthma (ALFA), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for FHS-Gen III
Posted on March 25, 2020
Data have been updated for the Framingham Heart Study (FHS) Third Generation (Gen III), OMNI 2, and New Offspring (NOS) Cohorts. The data now include examination data from the first 2 clinical exams, selected ancillary data and event follow-up through 2017. Also included are the OMNI 2 and NOS cohorts.
New Funding Opportunity: NHLBI Big Data Analysis Challenge
Posted on March 24, 2020
The NHLBI is inviting novel Solutions for the NHLBI Big Data Analysis Challenge: Creating New Paradigms for Heart Failure Research. The goal of the challenge is to foster innovation in computational analysis and machine learning approaches utilizing large-scale NHLBI-funded datasets to identify new paradigms in heart failure research. The challenge aims to address the need for new open source disease models that can define sub-categorizations of adult heart failure to serve as a springboard for new research hypotheses and tool development in areas of heart failure research from basic to clinical settings.
NHLBI will award up to a total of $250,000. Up to five (5) winners will be selected, with each winning up to $50,000. The competition period ends at NOON EDT on August 28, 2020.
For more information on this challenge please visit:
https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/NHLBI-heart-failure-data-challenge
For details on additional funding opportunities go to: Funding Opportunities
New Study: AsthmaNet-INFANT/AVICA (data)
Posted on March 18, 2020
A new study, AsthmaNet Individualized Therapy For Asthma in Toddlers (INFANT) and Acetaminophen Versus Ibuprofen in Children With Asthma (AVICA), has been posted to BioLINCC. Data from this study are available for requests.
New Study: ICARE (data)
Posted on March 17, 2020
A new study, Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care (ICARE), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for FHS-Offspring
Posted on March 10, 2020
Data have been updated for the Framingham Heart Study (FHS) Offspring (OS) and OMNI 1 Cohorts. The data now include Framingham Offspring examination data from the first 9 clinical exams and selected ancillary data and event follow-up through 2016. Also included are the first 4 exams from the OMNI 1 cohort.
Data Update for FHS-Cohort
Posted on March 9, 2020
Data have been updated for the Framingham Heart Study-Cohort (FHS-Cohort). The data now include examination data from the first 32 clinical exams, selected ancillary data, and event follow-up through 2016.
New Study: AsthmaNet-APRIL/OCELOT (data)
Posted on March 2, 2020
A new study, AsthmaNet Azithromycin for Preventing the Development of Upper Respiratory Tract Illness Into Lower Respiratory Tract Symptoms in Children (APRIL) and Oral Corticosteroids for Treating Episodes of Significant Lower Respiratory Tract Symptoms in Children (OCELOT), has been posted to BioLINCC. Data from this study are available for requests.
New Study: AsthmaNet-VIDA (data)
Posted on February 21, 2020
A new study, AsthmaNet Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma (VIDA), has been posted to BioLINCC. Data from this study are available for requests.
New Study: AsthmaNet-SIENA (data)
Posted on February 11, 2020
A new study, AsthmaNet Steroids in Eosinophil Negative Asthma (SIENA), has been posted to BioLINCC. Data from this study are available for requests.
New Study: AsthmaNet-STICS (data)
Posted on February 4, 2020
A new study, AsthmaNet Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS), has been posted to BioLINCC. Data from this study are available for requests.
New Study: AsthmaNet-BARD (data)
Posted on January 27, 2020
A new study, AsthmaNet Best African American Response to Asthma Drugs (BARD), has been posted to BioLINCC. Data from this study are available for requests.
New Study: ROC-PROHS (data)
Posted on January 16, 2020
A new study, Resuscitation Outcomes Consortium (ROC) Prehospital Resuscitation on Helicopter Study (PROHS), has been posted to BioLINCC. Data from this study are available for requests.
New Study: ROC-PART (data)
Posted on December 27, 2019
A new study, Resuscitation Outcomes Consortium (ROC) Pragmatic Trial of Airway Management in Out-of-Hospital Cardiac Arrest (PART), has been posted to BioLINCC. Data from this study are available for requests.
Data Update for CARDIA
Posted on December 6, 2019
Data have been updated for the CARDIA study (Coronary Artery Risk Development in Young Adults). Year 30 exam data and outcomes data with follow-up through 2016 are now available.
Data Update for MESA
Posted on November 15, 2019
Data have been updated for the Multi-Ethnic Study of Atherosclerosis (MESA) to include ancillary studies #047 and #075 on Vitamin D, #195 on Fatty Acid, and #200 on Total FFA. Now available are data through exam 5, follow-up event data through year 10, and data from eleven ancillary studies.
Data Update for ARIC Study
Posted on November 14, 2019
Data have been updated for the Atherosclerosis Risk in Communities Study (ARIC) study including cohort follow-up data through 2015 . Now available are data from v1-v5 examination cycles, collated annual follow-up communication data for contact years 2-26, and follow-up for mortality, heart disease, and stroke events through 2015 in addition to 7 ancillary studies.
New Study: BMT CTN-0501 (data)
Posted on November 1, 2019
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Multi-center, Open Label, Randomized Trial Comparing Single Versus Double Umbilical Cord Blood (UCB) Transplantation in Pediatric Patients With High Risk Leukemia and Myelodysplasia (0501), has been posted to BioLINCC. Data from this study are available for requests.
New Study: BMT CTN-0901 (data)
Posted on October 10, 2019
A new study, Blood and Marrow Transplant Clinical Trials Network (BMT CTN) A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia (0901), has been posted to BioLINCC. Data from this study are available for requests.
Funding Opportunities Added
Posted on August 30, 2019
New information regarding secondary data and/or biospecimen analysis funding opportunities from NHLBI, NIDDK, and FDA has been added to the funding opportunities page. These NIH Exploratory (R21) grant funding opportunities may be applicable to research using BioLINCC resources. Additionally included is an NHLBI released Notice of Special Interest (NOSI) on Data Science R01 applications. Please see the funding opportunities page, which includes links to the NIH grant announcements, for more information.